Significance of day-to-day glucose variability in patients after acute coronary syndrome

Table 2 Single correlation analysis between MODD and clinical characteristics, other indices of blood glucose fluctuation

Acute phase = 3–5 days after admission; chronic phase = 10–12 months after the disease onset; ΔEF = chronic phase EF–acute phase EF; ΔEDV = chronic phase EDV–acute phase EDV; ΔSV = chronic phase SV–acute phase SV
ADRR average daily risk range, AA arachidonic acid, apoA-I apolipoprotein A-I, apoB apolipoprotein B, apoE apolipoprotein E, CK creatine kinase, DHA docosahexaenoic acid, DHLA dihydrogammalinolenic acid, EDV end-systolic volume, eGFR estimated glomerular filtration rate, EPA eicosapentaenoic acid, HbA1c hemoglobin A1c, HBGI high blood glucose index, HDL high-density lipoprotein, LBGI low blood glucose index, LDL low-density lipoprotein, LVEF left ventricular ejection fraction, MAGE mean amplitude of glycemic excursions, MDA-LDL malondialdehyde-modified low-density lipoprotein, NT-proBNP N-terminal pro-brain natriuretic peptide, SV stroke volume, TG triglyceride

ISSN: 1471-2261